	Estimating the Underreporting of COVID-19 Burden in Selected Countries in Asia, Africa, the Middle East, and Latin America in the Post-pandemic Era. Pulm Ther Mendoza CF, Spinardi J, Chirila I, Spencer C, Kyaw MH, Yarnoff B. PMID: 42397628 [PubMed - as supplied by publisher]
	Effectiveness of the Approved Nirmatrelvir/Ritonavir and Molnupiravir Regimens for Treatment of Mild/Moderate Laboratory-Confirmed SARS-CoV-2 Infection in Patients Aged 18-64 Years in Hong Kong: A Population-Based Cohort Study. Clin Drug Investig Okoli GN, Lin Y, Wu P, Cowling BJ. PMID: 42397514 [PubMed - as supplied by publisher]
	Protection against SARS-CoV-2 infection is achieved when simvastatin is supplied before infection and causes membrane reorganisation. Infect Dis (Lond) Patzi-Churqui M, Huang A, Eriksson SG, Nyström K, Parmryd I. PMID: 42397149 [PubMed - as supplied by publisher]
	Predicting Nirmatrelvir Resistance in SARS-CoV-2 M(pro) Mutants with an Integrated Computational Framework. J Phys Chem B Zhao F, Xia W, Xu Y, Wu X, Hu S, Zhang JZH. PMID: 42396917 [PubMed - as supplied by publisher]
	Favipiravir tissue distribution and inhibitory quotients in preclinical models: towards a pipeline for evidence-based antiviral repurposing. J Antimicrob Chemother Petit PR, Touret F, Driouich JS, Paré A, de Lamballerie X, Marlin R, Contreras V, Relouzat F, Gallouët AS, Pascal Q, Guedj J, Le Grand R, Nougairède A, Solas C. PMID: 42396859 [PubMed - indexed for MEDLINE]
	COVID-19 Vaccine Reactogenicity Marks an Innate Inflammatory Response Associated With HLA Variation and Enhanced Protection. Res Sq Hollenbach J, Srivastava A, Chatzileontiadou D, Adhikari A, Suseno R, Lin S, Boquett J, Tuibeo J, Yusufali T, Peyser N, Farias T, Kichula K, Nguyen A, Jose I, Jayasinghe D, Leong S, Beatty A, Tarassi K, Kontou E, Maddumage J, Ampelakiotou K, Tsirogianni A, Dewar-Oldis M, Tu TM, Phan T, Barnard P, Sabatino J, Zoulas D, Ariens E, Mercer T, Grant E, D'Orsogna L, Smith C, Norman P, Marcus G, Olgin J, Pletcher MJ, Maiers M, Gras S. PMID: 42396522 [PubMed]
	Structure-Guided Design of Therapeutic Antibodies Targeting SARS-CoV-2 Omicron Variants. Res Sq Pallesen J, Du J, Wu Y, Ghosh S, Bayruns K, Sadeesh R, Weiner D. PMID: 42396495 [PubMed]
	Spatial Immune Model of Alveolar Lung Infection (SIMALI) Identifies Structural Determinants of Lung Inflammation. Res Sq Tasnim H, Forrest S, Hofmeyr S, Friedman A, Etemadpour R, Andrews A, Cannon J, Moses M, Mehdikhani H. PMID: 42396494 [PubMed]
	Surrogate virus neutralization test to determine salivary neutralizing antibody inhibition of ACE2 and SARS-CoV-2 spike RBD complex. Front Immunol Forsman D, Smith A, Pratt A, Comerford P, Sparano F, Peng C, Dean D. PMID: 42396438 [PubMed - indexed for MEDLINE]
	Differential COVID-19 Outcomes Across Lysosomal Disorders. medRxiv Byer BK, Butzin-Dozier Z, McGrath BM, Muenzer J, Clarke L, Haendel MA, O'Neil ST. PMID: 42396310 [PubMed]
	Smoothly Time-Varying Continuous Time Markov Chains in Phylogenetics. ArXiv Datta P, Lemey P, Suchard MA. PMID: 42396204 [PubMed]
	Anti-SARS-CoV-2 VHH and C7C peptide fused with Angiopep-2 efficiently traverse blood-brain barrier model and neutralizes virus. Front Microbiol Bhide M, Bhide K, Mochnacova E, Viglasky J, Kosturikova D, Kulkarni A. PMID: 42395902 [PubMed]
	Functional Genomic Evidence for Candidate Small Viral RNA-Mediated Epigenetic Interference in SARS-CoV-1 and SARS-CoV-2. Comput Struct Biotechnol J Paulson AR, Montoya V, Joy JB. PMID: 42395897 [PubMed]
	Systematic Modeling of Covalent Inhibitors of SARS-CoV-2 Main Protease and Its Mutants. ACS Catal Chen PP, Nandi A, Warshel A. PMID: 42395896 [PubMed]
	Molecular modeling of 7-propanamide benzoxaboroles as CPSF3 inhibitors through docking-based 3D-QSAR and molecular dynamics simulations. RSC Adv Ji L, Liu Y, Xu G. PMID: 42395772 [PubMed - as supplied by publisher]
	Thiazoles inhibit reactive oxygen and nitrogen species mediated diabetes mellitus: integrated in vitro and in silico insights. RSC Adv Aziz H. PMID: 42395771 [PubMed - as supplied by publisher]
	Rationally designed copper-deferiprone-phenanthroline complex as a dual anticancer and SARS-CoV-2 inhibitor. RSC Adv Mirzaei-Kalar Z, Khandar AA, White JM, Abolhasani H, Movahhed TK, Jouyban A. PMID: 42395751 [PubMed - as supplied by publisher]
	Post-infection immune response in adults with COVID-19 with and without nirmatrelvir-ritonavir treatment and virologic rebound. bioRxiv Ghimire D, Hasund CM, Colangeli JB, Liew MY, Abar E, Barry M, Alexandrescu A, Kotzen BL, Reynolds Z, Passell E, Mandell C, Smith-Sparks Z, Su K, Boucau J, Glover OT, Leeman B, Edelstein GE, Choudhary MC, Li Y, Patel N, Sparks JA, Barczak AK, Li JZ, Siedner MJ, Lemieux JE. PMID: 42395541 [PubMed]
	Development of GS-441524 Derivatives as Potent SARS-CoV-2 Mac1 Inhibitors via a Direct-to-Biology Approach. bioRxiv Peng K, Chakraborty S, Wallace SD, Noll JCG, Shang J, Lu X, Choi A, Whittaker G, Fromme JC, Lin H. PMID: 42395494 [PubMed]
	Long COVID and health-related quality of life: a systematic review of immune, inflammatory, and metabolic markers. Front Public Health Turebekova D, Kosherova B, Dauletkaliyeva Z, Shayakhmetova Y, Marchenko A, Solyanov D, Hendrixson V, Kadyrova I. PMID: 42395315 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 290068

Page 1 of 14504



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy